PIP4K2A: A promising drug target and biomarker for treating neurodegenerative diseases

Target Name: PIP4K2A

NCBI ID: G5305

PIP4K2A

PIP4K2A: A promising drug target and biomarker for treating neurodegenerative diseases

Introduction

PIP4K2A (phosphatidylinositol 5-phosphate 4-kinase type II alpha) is an enzyme involved in the intracellular signaling pathway known as the PI3K-Akt pathway. This pathway plays a crucial role in the regulation of various cellular processes, including cell survival, metabolism, and inflammation. The loss of this pathway's control can lead to the development of neurodegenerative diseases, such as Alzheimer's, Parkinson's, and Huntington's diseases.

Recent studies have identified PIP4K2A as a potential drug target and biomarker for treating neurodegenerative diseases. In this article, we will explore the biology of PIP4K2A and its potential as a therapeutic target.

Phosphatidylinositol 5-phosphate 4-kinase type II alpha (PIP4K2A)

PIP4K2A is an enzyme belonging to the PI3K-Akt signaling pathway. This pathway is a well-established regulator of various cellular processes, including cell survival, metabolism, and inflammation. The PI3K-Akt pathway is composed of several proteins, including PIP4K2A, PIP4K2B , and kinase A10.

PIP4K2A is a 120-kDa protein that is expressed in various tissues, including brain, heart, and liver. It is involved in the regulation of several cellular processes, including the intracellular signaling pathway known as the PI3K-Akt pathway. This pathway plays a crucial role in the regulation of various cellular processes, including cell survival, metabolism, and inflammation.

The PI3K-Akt pathway is a well-established regulator of various cellular processes, including cell survival, metabolism, and inflammation. The pathway is composed of several proteins, including PIP4K2A, PIP4K2B, and kinase A10.

PIP4K2A functions as a catalytic enzyme for the PI3K-Akt pathway. It catalyzes the conversion of phosphatidylinositol (PI) to phosphatidylinositol 5-phosphate (PIP5), which is a key step in the PI3K-Akt signaling pathway.

PIP4K2A is a critical enzyme for the regulation of cellular processes, including cell survival and metabolism. It has been shown to play a role in the regulation of various cellular processes, including the regulation of cell adhesion, migration, and the regulation of cellular signaling pathways.

PIP4K2A as a drug target

PIP4K2A has been identified as a potential drug target for the treatment of neurodegenerative diseases. Several studies have shown that the loss of PIP4K2A is associated with the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases.

In addition, PIP4K2A has been shown to play a role in the development of certain neurodegenerative diseases, such as Huntington's disease. Studies have shown that the loss of PIP4K2A is associated with the development of neurodegenerate symptoms in Huntington's disease.

PIP4K2A has also been shown to be a potential biomarker for the diagnosis of neurodegenerative diseases. The levels of PIP4K2A have been shown to be decreased in the brains of individuals with Alzheimer's and Parkinson's diseases.

PIP4K2A as a biomarker

PIP4K2A has also been shown to be a potential biomarker for the diagnosis of neurodegenerative diseases. The levels of PIP4K2A have been shown to be decreased in the brains of individuals with Alzheimer's and Parkinson's diseases.

In addition, PIP4K2A has been shown to be involved in

Protein Name: Phosphatidylinositol-5-phosphate 4-kinase Type 2 Alpha

Functions: Catalyzes the phosphorylation of phosphatidylinositol 5-phosphate (PtdIns5P) on the fourth hydroxyl of the myo-inositol ring, to form phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) (PubMed:9367159, PubMed:23326584). Has both ATP- and GTP-dependent kinase activities (PubMed:26774281). May exert its function by regulating the levels of PtdIns5P, which functions in the cytosol by increasing AKT activity and in the nucleus signals through ING2 (PubMed:18364242). May regulate the pool of cytosolic PtdIns5P in response to the activation of tyrosine phosphorylation (By similarity). Required for lysosome-peroxisome membrane contacts and intracellular cholesterol transport through modulating peroxisomal PtdIns(4,5)P2 level (PubMed:29353240). In collaboration with PIP4K2B, has a role in mediating autophagy in times of nutrient stress (By similarity). Required for autophagosome-lysosome fusion and the regulation of cellular lipid metabolism (PubMed:31091439). May be involved in thrombopoiesis, and the terminal maturation of megakaryocytes and regulation of their size (By similarity). Negatively regulates insulin signaling through a catalytic-independent mechanism (PubMed:31091439). PIP4Ks interact with PIP5Ks and suppress PIP5K-mediated PtdIns(4,5)P2 synthesis and insulin-dependent conversion to PtdIns(3,4,5)P3 (PubMed:31091439)

The "PIP4K2A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PIP4K2A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets